Surgery for Breast Cancer: 974 Real Stories

974 stories match breast cancer and surgery. 653 of them mention chemotherapy.

Cancer Stories

A patient, who was diagnosed with Breast CancerBreast Cancer

Stage IIIC triple-negative breast cancer with pembrolizumab-related HLH/DIC and pathologic complete response

Patient Info: Anonymized, Female, Under 40

Biomarkers: Triple-negative/HR-negative breast cancer with germline BRCA1 pathogenic mutation. HLH/DIC episode had high IL-6

Surgery confirmed ypT0ypN0 pathologic complete response after neoadjuvant carboplatin, paclitaxel, and pembrolizumab, and she remained recurrence-free while being monitored without additional cancer-directed treatment.

PubMed Central
OutcomeCancer-Free / NED
India, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: India's Survivor Story

Patient Info: India Robinson, Female, 40s | Stage II

As of January 2025, India had completed Stage II breast cancer treatment and had returned to work, the gym and daily life after robotic lymphatic microsurgery resolved breast lymphedema; the story does not explicitly state NED.

Cleveland Clinic
OutcomeSurvivorship / Surveillance
MB
Breast Cancer

Metastatic breast cancer with receptor evolution: sequential endocrine, immunotherapy, CDK4/6, and antibody-drug conjugate treatment

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Markers changed over time: initial tumor ER-positive/HER2-negative; local recurrence triple-negative/HER2-low; pleural fluid ER-negative.

Metastatic Site: mediastinal lymph nodes, pleura; pulmonary nodules…

More than 7 years after diagnosis, she remained on sequential systemic therapy for metastatic breast cancer, with at least a partial response 3 months after starting sacituzumab govitecan for presumed triple-negative pleural disease.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Stage III Breast Cancer Complicated by a Large Liver Abscess

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: ER-positive, HER2-negative

Continuing adjuvant anastrozole and oncology follow-up after mastectomy for Stage III breast cancer.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I triple-negative solid basaloid adenoid cystic breast cancer treated with mastectomy and oral chemotherapy

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: Current tumor was triple-negative with high Ki-67 and c-kit/CK7 staining. Prior breast cancer was ER-positive, HER2-positive, PR-negative.

One year after mastectomy and postoperative tegafur-gimeracil-oteracil potassium, she was recovering well without signs of metastasis.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

HER2-Positive Breast Cancer With Metastatic Progression and Drug-Induced Lupus During T-DM1

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive, PR-negative, HER2-positive

Metastatic Site: bones, axillary lymph nodes, intra-abdominal lymph…

More than 5 years after her March 2018 diagnosis, she was living with metastatic breast cancer, but T-DM1 had been stopped after disease progression in 2023.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Two sisters with invasive lobular breast cancer and a shared CDH1 mutation

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Biomarkers: Both sisters had pathogenic CDH1 p.. Breast cancers were HER2-negative; older sister also had a PTCH1 variant of uncertain significance.

As of January 2025, both sisters were under ongoing hereditary diffuse gastric cancer surveillance with annual EGD after breast cancer treatment; no signs of HDGC or metastatic breast cancer were reported.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Breast CancerBreast Cancer

Prior breast cancer treated with radiation, then radiation-related heart damage

Patient Info: Anonymized, Female, 60s

Breast cancer treatment had been completed 10 years earlier; the case mainly documents successful surgery for radiation-associated coronary and aortic valve disease, with no major cardiac events at 5 years.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV luminal A breast cancer: liver resection and disease-free follow-up

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: luminal A; ER-positive; PgR-positive; HER2-negative

Metastatic Site: lung, liver

Disease-free after R0 hepatic segmentectomy for breast cancer liver metastasis, with May 2021 MRI showing no remaining liver nodules while she continued maintenance letrozole and goserelin.

PubMed Central
OutcomeCancer-Free / NED
Marissa, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Marissa's Survivor Story

Patient Info: Marissa Sweitzer, Female, Under 40

Biomarkers: ER-negative; PR-negative; HER2-negative; no breast cancer genetic mutation reported

As of December 2024, Marissa had a complete response to treatment and no evidence of cancer after postpartum triple-negative breast cancer involving the breast and lymph nodes was treated with chemotherapy, double mastectomy and 5 weeks of radiation.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage 4 HR-positive breast cancer: stable disease on ribociclib

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative

Metastatic Site: left iliac bone

Metastatic HR-positive, HER2-negative breast cancer remained without progression as of October 2024 while she continued ribociclib 400 mg plus letrozole after SBRT to a left iliac bone metastasis.

PubMed Central
OutcomeLiving With Cancer
Juliette, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Juliette's Survivor Story

Patient Info: Juliette Landgrave, Female, Under 40

Biomarkers: ER-negative; PR-negative; HER2-negative

After egg preservation, 16 rounds of chemotherapy with complete response, lumpectomy, 25 radiation sessions and 1 year of immunotherapy, Juliette was cancer-free as of December 2024.

City of Hope
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Breast Cancer Recurrence in the Small Intestine and Bone More Than 5 Years After Diagnosis

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Initial ER-positive, PR-positive, HER2-negative; metastatic lesion ER-negative, PR-negative, triple negative

Metastatic Site: small intestine, bone, right fallopian tube

More than 5 years after her December 2018 diagnosis, she was alive at 1-year follow-up after metastatic recurrence, with multiple bone metastases still present.

PubMed Central
OutcomeLiving With Cancer